View Single Post
Old 17 April 2018, 02:24 AM   #840
cornerstore
"TRF" Member
 
Join Date: Sep 2009
Location: Canada
Posts: 3,996
Quote:
Originally Posted by bing240sx View Post
nice news from APH Q3 report this morning. 100% increasein sales, $0.08 EPS. on the call Vic said they will release their retail brands this week.

Maricann also had a big license come through today and a big acquisition late last week.

Canopy announced a doubling of their overall capacity with a license last week and acquired 100% of a small European distributor.

Hopefully this will be a nice steady green week to get us on our way back to where we were.
Here is the fine print
Gross profit for the second quarter was $8,570, compared with $3,569 in the same quarter in the prior year and $6,202 in the previous quarter. The increase in gross profit from the prior year is consistent with the much larger patient base over the prior year, improvement in the cost per gram metrics, the one month of sales from Broken Coast offset and the increase in the fair value adjustment for biological assets.

Net income for the three months ended Feb. 28, 2018, was $12,945 or eight cents per share as opposed to a net income of $4,950 or four cents per share in the same period of the prior year, an increase of more than 161 per cent. The increase in net income relates to the continued strength of Aphria's investment portfolio, including its realized gain on sale of its non-escrowed shares in Liberty Health Sciences Ltd. in the quarter.
cornerstore is offline   Reply With Quote